Skip to main content
NASDAQ:BMRN

BioMarin Pharmaceutical SEC Filings & 10K Form

$76.93
+1.42 (+1.88 %)
(As of 05/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$75.59
$77.52
50-Day Range
$74.76
$81.16
52-Week Range
$71.35
$131.95
Volume933,064 shs
Average Volume1.19 million shs
Market Capitalization$14.06 billion
P/E Ratio17.60
Dividend YieldN/A
Beta0.71

SEC Filings

BioMarin Pharmaceutical (NASDAQ:BMRN) SEC Filings

DateFilerForm TypeView
05/12/2021
6:21 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2021
6:42 PM
BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2021
8:07 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2021
6:48 PM
BioMarin Pharmaceutical (Issuer)
MEIER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2021
7:46 PM
BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
7:27 PM
BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2021
7:24 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2021
1:10 PM
BioMarin Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2021
7:44 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/20/2021
8:53 PM
BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/13/2021
3:31 PM
BioMarin Pharmaceutical (Filer)
Form DEFA14A
04/13/2021
3:30 PM
BioMarin Pharmaceutical (Filer)
Form DEF 14A
04/09/2021
4:57 PM
Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
6:35 PM
BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2021
1:17 PM
Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2021
4:45 PM
Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2021
8:22 PM
BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2021
8:12 PM
BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2021
8:00 PM
BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2021
7:50 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2021
7:40 PM
Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2021
8:01 PM
Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2021
8:42 PM
BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2021
8:39 PM
BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2021
8:35 PM
BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2021
8:31 PM
BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2021
8:27 PM
Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2021
8:24 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2021
8:21 PM
Acosta Andrea (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2021
7:26 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2021
4:59 PM
BioMarin Pharmaceutical (Issuer)
GREY MICHAEL G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2021
10:02 AM
BioMarin Pharmaceutical (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Form SC 13G/A
02/26/2021
2:16 PM
BioMarin Pharmaceutical (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2021
3:09 PM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2021
7:38 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
3:31 PM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2021
8:22 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2021
4:28 PM
BioMarin Pharmaceutical (Issuer)
Ho Maykin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2021
3:35 PM
BioMarin Pharmaceutical (Issuer)
Ho Maykin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/18/2021
8:45 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2021
5:43 PM
BioMarin Pharmaceutical (Issuer)
LAWLIS V BRYAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
2:58 PM
BioMarin Pharmaceutical (Subject)
Capital Research Global Investors (Filed by)
Form SC 13G/A
02/12/2021
2:10 PM
BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/11/2021
8:35 PM
Acosta Andrea (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/11/2021
2:42 PM
BioMarin Pharmaceutical (Subject)
DODGE & COX (Filed by)
Form SC 13G
02/05/2021
7:03 AM
BioMarin Pharmaceutical (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
02/04/2021
6:48 PM
BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2021
6:00 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2021
6:35 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2021
8:56 AM
BioMarin Pharmaceutical (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Form SC 13G/A
12/30/2020
7:02 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
3:30 PM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2020
11:53 AM
BioMarin Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
3:11 PM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2020
6:17 PM
Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2020
7:35 PM
BioMarin Pharmaceutical (Issuer)
HERON ELAINE J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2020
11:00 AM
BioMarin Pharmaceutical (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Form SC 13G/A
09/09/2020
10:20 AM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/01/2020
8:44 PM
BioMarin Pharmaceutical (Issuer)
PYOTT DAVID E I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2020
5:56 PM
BioMarin Pharmaceutical (Issuer)
GREY MICHAEL G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2020
8:15 PM
Acosta Andrea (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/22/2020
4:32 PM
BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2020
8:22 PM
Acosta Andrea (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2020
8:32 PM
BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
12:40 PM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2020
8:48 PM
BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
1:11 PM
BioMarin Pharmaceutical (Issuer)
Dere Willard H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2020
6:24 PM
Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2020
5:04 PM
BioMarin Pharmaceutical (Issuer)
LAWLIS V BRYAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2020
3:15 PM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2020
5:48 PM
BioMarin Pharmaceutical (Issuer)
Slamon Dennis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
5:32 PM
BioMarin Pharmaceutical (Issuer)
PYOTT DAVID E I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
5:07 PM
BioMarin Pharmaceutical (Issuer)
MEIER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
4:38 PM
BioMarin Pharmaceutical (Issuer)
LAWLIS V BRYAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
3:50 PM
BioMarin Pharmaceutical (Issuer)
HERON ELAINE J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2020
3:17 PM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2020
12:51 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2020
7:10 PM
BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2020
5:28 PM
BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/05/2020
6:22 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2020
8:45 PM
BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2020
12:54 PM
BioMarin Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2020
6:40 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2020
1:37 PM
BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2020
4:15 PM
BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2020
8:00 AM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2020
3:15 PM
BioMarin Pharmaceutical (Filer)
Form DEFA14A
04/14/2020
3:15 PM
BioMarin Pharmaceutical (Filer)
Form DEF 14A
04/13/2020
5:24 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2020
6:58 PM
Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2020
7:54 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2020
7:39 PM
Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2020
7:34 PM
Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2020
8:07 PM
BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2020
7:57 PM
BAFFI ROBERT (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2020
7:53 PM
BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2020
7:48 PM
BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2020
7:42 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2020
7:37 PM
Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2020
7:46 PM
BioMarin Pharmaceutical (Issuer)
LAWLIS V BRYAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 5/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.